Isoniazid

IsoniazidIsoniazid is a prodrug derivative of nicotinic acid that is used as an antibiotic compound against Mycobactrium tuberculosis, M. bovis, and other mycobacteria. This prodrug is transformed by catalase peroxidases, where its active form inhibits an enoyl reductase (InhA). Inhibition of InhA compromises bacterial cell walls by preventing mycolic acid synthesis, disrupting fluid homeostasis and leading to cell death. Product Specifications Isoniazid

Soybean trypsin inhibitor forms a 1:1 complex with the active protease site

antibodies

and replication stress responses

Purpose: To distinguish recombinant from non-recombinant bacterial colonies using lacZα-complementation

D-lactitol

Inhibiting viral DNA polymerase activity

Upon receipt store at 4°C

GelGreen™ 10

In Vivo Bioluminescent Imaging in Endotoxin-Sensitive Animal Models

which both suppresses ethylene evolution and degrades gamma-aminobutyric acid (GABA) during co-cultivation

or direct contact with skin or eyes

Tetracycline is used in multidrug resistance studies and in cell culture applications as a selective agent